| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
1997-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1999-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-19990082173-A |
| titleOfInvention |
Bladder Cancer Detection and Evaluation Method |
| abstract |
The present invention relates to a novel bladder cancer evaluation and detection method. The method of the present invention is based on the finding that standard amounts of hyaluronic acid (HA) and hyaluronidase (HAase) are diagnostic markers in the detection, grading, therapeutic efficacy and monitoring of tumor recurrence of bladder cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190079710-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220168410-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101439975-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101439977-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101439981-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013103197-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100475449-B1 |
| priorityDate |
1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |